Avid Bioservices (CDMO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Avid Bioservices Revenue Highlights

Latest Revenue (Y)

$149.27M

Latest Revenue (Q)

$40.17M

Main Segment (Y)

Manufacturing Revenue

Main Geography (Y)

Manufacturing Revenue

Avid Bioservices Revenue by Period

Avid Bioservices Revenue by Year

Date	Revenue	Change
2023-04-30	$149.27M	24.81%
2022-04-30	$119.60M	24.75%
2021-04-30	$95.87M	60.58%
2020-04-30	$59.70M	11.38%
2019-04-30	$53.60M	-0.03%
2018-04-30	$53.62M	-6.96%
2017-04-30	$57.63M	28.97%
2016-04-30	$44.69M	66.86%
2015-04-30	$26.78M	19.55%
2014-04-30	$22.40M	3.31%
2013-04-30	$21.68M	42.34%
2012-04-30	$15.23M	12.90%
2011-04-30	$13.49M	-51.72%
2010-04-30	$27.94M	53.95%
2009-04-30	$18.15M	197.90%
2008-04-30	$6.09M	64.32%
2007-04-30	$3.71M	16.13%
2006-04-30	$3.19M	-35.61%
2005-04-30	$4.96M	49.64%
2004-04-30	$3.31M	-15.48%
2003-04-30	$3.92M	4.12%
2002-04-30	$3.77M	284.68%
2001-04-30	$979.00K	97800.00%
2000-04-30	$1.00K	-99.00%
1999-04-30	$100.00K	-80.00%
1998-04-30	$500.00K	66.67%
1997-04-30	$300.00K	-90.32%
1996-04-30	$3.10M	3000.00%
1995-04-30	$100.00K	-

Avid Bioservices generated $149.27M in revenue during NA 2023, up 24.81% compared to the previous quarter, and up 278.37% compared to the same period a year ago.

Avid Bioservices Revenue by Quarter

Date	Revenue	Change
2024-07-31	$40.17M	-6.52%
2024-04-30	$42.98M	27.09%
2024-01-31	$33.81M	33.16%
2023-10-31	$25.39M	-32.69%
2023-07-31	$37.73M	-5.21%
2023-04-30	$39.80M	4.68%
2023-01-31	$38.02M	9.38%
2022-10-31	$34.76M	-5.27%
2022-07-31	$36.69M	17.50%
2022-04-30	$31.23M	-0.90%
2022-01-31	$31.51M	20.68%
2021-10-31	$26.11M	-15.10%
2021-07-31	$30.75M	11.40%
2021-04-30	$27.61M	26.60%
2021-01-31	$21.81M	3.52%
2020-10-31	$21.06M	-17.04%
2020-07-31	$25.39M	102.33%
2020-04-30	$12.55M	-7.62%
2020-01-31	$13.59M	-25.82%
2019-10-31	$18.31M	20.05%
2019-07-31	$15.25M	-10.56%
2019-04-30	$17.05M	23.76%
2019-01-31	$13.78M	35.40%
2018-10-31	$10.18M	-19.15%
2018-07-31	$12.59M	81.32%
2018-04-30	$6.94M	1.82%
2018-01-31	$6.82M	-46.65%
2017-10-31	$12.78M	-52.79%
2017-07-31	$27.08M	51.23%
2017-04-30	$17.90M	66.60%
2017-01-31	$10.75M	-54.01%
2016-10-31	$23.37M	316.65%
2016-07-31	$5.61M	-70.14%
2016-04-30	$18.78M	179.97%
2016-01-31	$6.71M	-29.55%
2015-10-31	$9.52M	-1.53%
2015-07-31	$9.67M	3.90%
2015-04-30	$9.31M	63.96%
2015-01-31	$5.68M	-9.89%
2014-10-31	$6.30M	14.63%
2014-07-31	$5.50M	-15.11%
2014-04-30	$6.47M	66.64%
2014-01-31	$3.88M	-47.17%
2013-10-31	$7.35M	56.87%
2013-07-31	$4.69M	10.20%
2013-04-30	$4.25M	-39.57%
2013-01-31	$7.04M	14.66%
2012-10-31	$6.14M	44.41%
2012-07-31	$4.25M	105.86%
2012-04-30	$2.06M	-37.06%
2012-01-31	$3.28M	-22.47%
2011-10-31	$4.23M	-25.16%
2011-07-31	$5.66M	107.22%
2011-04-30	$2.73M	-5.34%
2011-01-31	$2.88M	-38.28%
2010-10-31	$4.67M	45.56%
2010-07-31	$3.21M	-27.40%
2010-04-30	$4.42M	-55.25%
2010-01-31	$9.88M	43.23%
2009-10-31	$6.90M	2.16%
2009-07-31	$6.75M	-14.20%
2009-04-30	$7.87M	15.25%
2009-01-31	$6.83M	251.67%
2008-10-31	$1.94M	27.95%
2008-07-31	$1.52M	68.37%
2008-04-30	$901.00K	-46.21%
2008-01-31	$1.68M	-

Avid Bioservices generated $40.17M in revenue during Q1 2025, up -6.52% compared to the previous quarter, and up 100.94% compared to the same period a year ago.

Avid Bioservices Revenue Breakdown

Avid Bioservices Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Apr 23	Apr 22	Apr 21	Apr 20	Apr 19
Process Development Revenue	$23.85M	$20.32M	$12.19M	$7.66M	$10.17M
Manufacturing Revenue	$125.42M	$99.28M	$83.68M	$52.05M	$43.43M

Avid Bioservices's latest annual revenue breakdown by segment (product or service), as of Apr 23: Manufacturing Revenue (84.02%), and Process Development Revenue (15.98%).

Quarterly Revenue by Product

Product/Service	Jul 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Jan 20	Oct 19	Jul 19	Apr 19	Jan 19
Manufacturing Revenues	$33.97M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Manufacturing Revenue	-	$20.13M	$33.42M	$34.14M	$32.18M	$27.61M	$31.48M	$25.42M	$26.17M	$22.01M	$25.68M	$23.27M	$17.89M	$18.45M	$24.06M	$11.53M	$15.99M	$12.91M	$15.12M	-
Process Development Revenue	-	$5.27M	$4.31M	$5.66M	$5.84M	$7.14M	$5.21M	$5.80M	$5.34M	$4.10M	$5.08M	$4.33M	$3.91M	$2.62M	$1.33M	$2.06M	$2.32M	$2.35M	$1.94M	$3.01M

Avid Bioservices's latest quarterly revenue breakdown by segment (product or service), as of Jul 24: Manufacturing Revenues (100.00%).

Avid Bioservices Revenue Breakdown by Country

Annual Revenue by Country

Country	Apr 22	Apr 21	Apr 20	Apr 19
Process Development Revenue	$20.32M	$12.19M	$7.66M	$10.17M
Manufacturing Revenue	$99.28M	$83.68M	$52.05M	$43.43M

Avid Bioservices's latest annual revenue breakdown by geography, as of Apr 22: Manufacturing Revenue (83.01%), and Process Development Revenue (16.99%).

Quarterly Revenue by Country

Country	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Jan 20	Oct 19	Jul 19	Apr 19	Jan 19	Oct 18	Jul 18
Manufacturing Revenue	$32.18M	$27.61M	$31.48M	$25.42M	$26.17M	$22.01M	$25.68M	$23.27M	$17.89M	$18.45M	$24.06M	$11.53M	$15.99M	$12.91M	$15.12M	-	-	-
Process Development Revenue	$5.84M	$7.14M	$5.21M	$5.80M	$5.34M	$4.10M	$5.08M	$4.33M	$3.91M	$2.62M	$1.33M	$2.06M	$2.32M	$2.35M	$1.94M	$3.01M	$2.94M	$2.29M

Avid Bioservices's latest quarterly revenue breakdown by geography, as of Jan 23: Manufacturing Revenue (84.65%), and Process Development Revenue (15.35%).

Avid Bioservices Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
IMCR	Immunocore	$249.43M	$75.40M
MIRM	Mirum Pharmaceuticals	$186.37M	$77.88M
CDMO	Avid Bioservices	$149.27M	$40.17M
BCYC	Bicycle Therapeutics	$26.98M	$2.68M
IDYA	IDEAYA Biosciences	$23.39M	-
ADAG	Adagene	$18.11M	$833.34K
ANAB	AnaptysBio	$17.16M	$30.02M
MGTX	MeiraGTx	$14.02M	$10.91M
CYTK	Cytokinetics	$7.53M	$463.00K
KDNY	Chinook Therapeutics	$6.13M	$1.01M
CRNX	Crinetics Pharmaceuticals	$4.01M	-
LYRA	Lyra Therapeutics	$1.56M	$195.00K
FIXX	Q32 Bio	$1.16M	-
KRTX	Karuna Therapeutics	$654.00K	-
KROS	Keros Therapeutics	$151.00K	$37.00K
ANEB	Anebulo Pharmaceuticals	-	-
DICE	DICE Therapeutics	-	-
DYN	Dyne Therapeutics	-	-
CERE	Cerevel Therapeutics	-	-
ACRV	Acrivon Therapeutics	-	-
MLYS	Mineralys Therapeutics	-	-
LRMR	Larimar Therapeutics	-	-
KALV	KalVista Pharmaceuticals	-	-
EWTX	Edgewise Therapeutics	-	-

CDMO Revenue FAQ

What is Avid Bioservices’s yearly revenue?

Avid Bioservices's yearly revenue for 2023 was $149.27M, representing an increase of 24.81% compared to 2022. The company's yearly revenue for 2022 was $119.6M, representing an increase of 24.75% compared to 2021. CDMO's yearly revenue for 2021 was $95.87M, representing an increase of 60.58% compared to 2020.

What is Avid Bioservices’s quarterly revenue?

Avid Bioservices's quarterly revenue for Q1 2025 was $40.17M, a -6.52% decrease from the previous quarter (Q4 2024), and a 6.49% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $42.98M, a 27.09% increase from the previous quarter (Q3 2024), and a 7.98% increase year-over-year (Q4 2023). CDMO's quarterly revenue for Q3 2024 was $33.82M, a 33.16% increase from the previous quarter (Q2 2024), and a -11.06% decrease year-over-year (Q3 2023).

What is Avid Bioservices’s revenue growth rate?

Avid Bioservices's revenue growth rate for the last 3 years (2021-2023) was 55.70%, and for the last 5 years (2019-2023) was 178.47%.

What are Avid Bioservices’s revenue streams?

Avid Bioservices's revenue streams in r 23 are Process Development Revenue, and Manufacturing Revenue. Process Development Revenue generated $23.85M in revenue, accounting 15.98% of the company's total revenue, up 17.40% year-over-year. Manufacturing Revenue generated $125.42M in revenue, accounting 84.02% of the company's total revenue, up 26.32% year-over-year.

What is Avid Bioservices’s main source of revenue?

For the fiscal year ending Apr 23, the largest source of revenue of Avid Bioservices was Manufacturing Revenue. This segment made a revenue of $125.42M, representing 84.02% of the company's total revenue.